KE Spotlight
Filter
-
HKU Successfully Developed Oral Arsenic Trioxide as the First Ever Patented Prescription Drug in Hong Kong: A Success Story of Hong Kong Innovation
A research team at our Department of Medicine and the Queen Marry Hospital has spent a decade developing oral arsenic trioxide from a research project to a prescription medication that has secured a US patent. For the first time, a drug developed entirely in Hong Kong is poised to attain global status as a prescription medication.
Read More -
Response to Severe Acute Respiratory Syndrome (SARS)
In leading the HKU response to SARS, the Li Ka Shing Faculty of Medicine turned a serious threat to the community into a research and knowledge exchange opportunity that extended far beyond the visible medical and biological research to include multidisciplinary research and knowledge exchange with the society in areas ranging from engineering and architecture, to epidemiology and psychological counseling.
Read More